336 related articles for article (PubMed ID: 23591149)
1. Current status of liposomal porphyrinoid photosensitizers.
Skupin-Mrugalska P; Piskorz J; Goslinski T; Mielcarek J; Konopka K; Düzgüneş N
Drug Discov Today; 2013 Aug; 18(15-16):776-84. PubMed ID: 23591149
[TBL] [Abstract][Full Text] [Related]
2. Delivery of lipophilic porphyrin by liposome vehicles: preparation and photodynamic therapy activity against cancer cell lines.
Temizel E; Sagir T; Ayan E; Isik S; Ozturk R
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):537-45. PubMed ID: 25107838
[TBL] [Abstract][Full Text] [Related]
3. Liposomes for photodynamic therapy.
Derycke AS; de Witte PA
Adv Drug Deliv Rev; 2004 Jan; 56(1):17-30. PubMed ID: 14706443
[TBL] [Abstract][Full Text] [Related]
4. Liposome-encapsulated photosensitizers against bacteria.
Chen C; Chen C; Yang J; Tsai T
Recent Pat Antiinfect Drug Discov; 2013 Aug; 8(2):100-7. PubMed ID: 23550544
[TBL] [Abstract][Full Text] [Related]
5. Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy.
Muehlmann LA; Joanitti GA; Silva JR; Longo JP; Azevedo RB
Braz J Med Biol Res; 2011 Aug; 44(8):729-37. PubMed ID: 21969965
[TBL] [Abstract][Full Text] [Related]
6. Liposomal nanostructures for photosensitizer delivery.
Jin CS; Zheng G
Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
[TBL] [Abstract][Full Text] [Related]
7. Liposomal delivery of photosensitising agents.
Chen B; Pogue BW; Hasan T
Expert Opin Drug Deliv; 2005 May; 2(3):477-87. PubMed ID: 16296769
[TBL] [Abstract][Full Text] [Related]
8. Liposomal Form of Tetra(Aryl)Tetracyanoporphyrazine: Physical Properties and Photodynamic Activity In Vitro.
Yudintsev AV; Shilyagina NY; Dyakova DV; Lermontova SA; Klapshina LG; Guryev EL; Balalaeva IV; Vodeneev VA
J Fluoresc; 2018 Mar; 28(2):513-522. PubMed ID: 29374365
[TBL] [Abstract][Full Text] [Related]
9. Intensive tumor suppression by anti-angiogenic photodynamic therapy with polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Nango M; Oku N
Cell Mol Biol Lett; 2002; 7(2):301. PubMed ID: 12097971
[No Abstract] [Full Text] [Related]
10. Association of acenaphthoporphyrins with liposomes for the photodynamic treatment of leishmaniasis.
Gardner DM; Taylor VM; Cedeño DL; Padhee S; Robledo SM; Jones MA; Lash TD; Vélez ID
Photochem Photobiol; 2010; 86(3):645-52. PubMed ID: 20202163
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of cancer with liposomal photosensitizers.
Düzgüneş N; Piskorz J; Skupin-Mrugalska P; Goslinski T; Mielcarek J; Konopka K
Ther Deliv; 2018 Nov; 9(11):823-832. PubMed ID: 30444459
[TBL] [Abstract][Full Text] [Related]
12. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.
O'Connor AE; Gallagher WM; Byrne AT
Photochem Photobiol; 2009; 85(5):1053-74. PubMed ID: 19682322
[TBL] [Abstract][Full Text] [Related]
13. Nanophotosensitizers toward advanced photodynamic therapy of Cancer.
Lim CK; Heo J; Shin S; Jeong K; Seo YH; Jang WD; Park CR; Park SY; Kim S; Kwon IC
Cancer Lett; 2013 Jul; 334(2):176-87. PubMed ID: 23017942
[TBL] [Abstract][Full Text] [Related]
14. Current clinical and preclinical photosensitizers for use in photodynamic therapy.
Detty MR; Gibson SL; Wagner SJ
J Med Chem; 2004 Jul; 47(16):3897-915. PubMed ID: 15267226
[No Abstract] [Full Text] [Related]
15. Strategies for delivering porphyrinoid-based photosensitizers in therapeutic applications.
Samaroo D; Perez E; Aggarwal A; Wills A; O'Connor N
Ther Deliv; 2014 Jul; 5(7):859-72. PubMed ID: 25287390
[TBL] [Abstract][Full Text] [Related]
16. Novel nanostructural photosensitizers for photodynamic therapy: in vitro studies.
Nawalany K; Rusin A; Kepczynski M; Filipczak P; Kumorek M; Kozik B; Weitman H; Ehrenberg B; Krawczyk Z; Nowakowska M
Int J Pharm; 2012 Jul; 430(1-2):129-40. PubMed ID: 22525077
[TBL] [Abstract][Full Text] [Related]
17. [New trends and safety of photodynamic therapy].
Osmałek T; Gośliński T; Mielcarek J; Osmałek E
Przegl Lek; 2012; 69(11):1205-8. PubMed ID: 23646448
[TBL] [Abstract][Full Text] [Related]
18. Bipolar tetraether lipids derived from thermoacidophilic archaeon Sulfolobus acidocaldarius for membrane stabilization of chlorin e6 based liposomes for photodynamic therapy.
Mahmoud G; Jedelská J; Strehlow B; Bakowsky U
Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):88-98. PubMed ID: 25936859
[TBL] [Abstract][Full Text] [Related]
19. Cancer, Photodynamic Therapy and Porphyrin-Type Derivatives.
Gomes ATPC; Neves MGPMS; Cavaleiro JAS
An Acad Bras Cienc; 2018; 90(1 Suppl 2):993-1026. PubMed ID: 29873666
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminium phthalocyanine.
Sutoris K; Vetvicka D; Horak L; Benes J; Nekvasil M; Jezek P; Zadinova M; Pouckova P
Anticancer Res; 2012 Sep; 32(9):3769-74. PubMed ID: 22993318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
